Company intelligence / Profile preview

E15 Capital

Hong Kong, Hong Kong

Ownership: Private
Development stage: Other

Overview

E15 VC is a Hong Kong-based venture capital firm, also referred to as E15 Ventures, that invests in deep technology companies across sectors including information technology, industrials, and selected healthcare opportunities. Available public sources describe it as an active venture investor founded in 2017 and operating globally with a stage-agnostic strategy. While the firm has made investments in some healthcare and drug discovery companies, it does not appear to be an operating biotech, pharma, or healthcare company itself. The requested name "E15 Capital" most likely refers to this investment firm rather than a life sciences developer.

Industry: Investors

Beyond the preview

Go deeper on E15 Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on E15 Capital.

Explore the full profile